HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Schisandrin derivative

HCID 119112
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
61301-33-5
Standard SMILES
COc1c2c(cc3c1-c1c(cc4c(c1OC)OCO4)CC(C)C(C)C3)OCO2
InChIKey
HTBWBWWADZJXID-UHFFFAOYSA-N
Molecular formula
C22H24O6
Average molar mass
384.4 g/mol
Monoisotopic mass
384.15728848

Overview

schisandrin C has been reported in Schisandra sphenanthera and Schisandra chinensis with data available.

Names & identifiers

Preferred name
Schisandrin derivative
IUPAC
3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.02,10.04,8.017,21]docosa-1(22),2,4(8),9,15,17(21)-hexaene
English name
WUWEIZISU C
Molecular formula
C22H24O6
Molecular weight
384.42

Names & synonyms

Schisandrin derivativeNSC609258Schizandrin-C;Wuweizisu-CMFCD0027217066138-32-7Schisandrin dervativeR-(+)-Wuweizisu CSchisandrin C [M+H]+orb3171757SCHEMBL12280310Schisandrin C, >=98% (HPLC)CCG-268455
Show more names
SCHIZANDRIN CWUWEIZISU C,8-dimethyl-Schizandrin C-RM(S)-(-)-Schisandrin CWUWEIZISU C USP/EP/BPSchisandrin C (Standard)Schisandrin C >=98% (HPLC)Schisandrin C (Schizandrin-CSchisandrin C, 10 mM in DMSO
EBC-615468NSC-609258NCGC00385072-01AC-34835DA-67487LS-14945T129700[1,3]Dioxolo[4'',5'']benzo[1'',2'':3',4']cycloocta[1',2':4,5]benzo[1,2-d]-1,3-dioxole, 5,6,7,8-tetrahydro-13,14-dimethoxy-6,7-dimethyl-

Database identifiers

CAS
61301-33-5

Properties

Computed structural properties

XLogP
5
Topological polar surface area
55.4 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
6
Rotatable bonds
2
Heavy atoms
28
Formal charge
0
Complexity
509

Physicochemical properties

Melting point
122 · 122-123℃
Boiling point
549.2 · 549.2±50.0 °C(Predicted)
Density
1.232 · 1.232
storage temp.
2 · 2-8°C
solubility
8.33 mg/mL · DMSO : 8.33 mg/mL (21.67 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
form
powder
color
White
Major Application
metabolomicsvitamins, nutraceuticals, and natural products
InChI
1S/C22H24O6/c1-11-5-13-7-15-19(27-9-25-15)21(23-3)17(13)18-14(6-12(11)2)8-16-20(22(18)24-4)28-10-26-16/h7-8,11-12H,5-6,9-10H2,1-4H3
InChIKey
HTBWBWWADZJXID-UHFFFAOYSA-N
SMILES
COC1=C2C(OCO2)=CC3=C1C(C(OC)=C(OCO4)C4=C5)=C5CC(C)C(C)C3
LogP
5.623 · 5.623 (est)
FDA UNII
8754 W6B3G · C8754W6B3G
UNSPSC Code
41116107 · 41116107
NACRES
25 · NA.25

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
Signal word
Warning
Symbol(GHS)
GHS07,GHS09
Storage Class
11 - Combustible Solids
Hazard statements
H302-H410
Precautionary statements
P264-P270-P301+P312-P330-P501-P273-P391-P501

Chemistry & industry

Applications · 2 items

DescriptionSchisandrin C is a lignan originally isolated from Schizandrae that has diverse biological activities. It decreases viability of U937 cells in a concentration-dependent manner and induces cell cycle arrest at the G1 phase when used at a concentration of 100 μM. Schisandrin C (5-20 μM) decreases hydrogen peroxide-induced cell death and production of reactive oxygen species (ROS) in C2C12 skeletal muscle cells. It also decreases levels of matrix metalloproteinase-2 (MMP-2), MMP-9, COX-2, VCAM-1, IL-1β, and TNF-α in hydrogen peroxide-stimulated C2C12 cells. Schisandrin C decreases lipoteichoic acid-induced production of nitric oxide (NO), prostaglandin E2 (PGE2; ), TNF-α, IL-1β, and IL-6 in mouse primary microglia. In vivo, schisandrin C (200 mg/kg) decreases serum alanine amino transferase (ALT) and aspartate amino transferase (AST) activity, increases hepatic mitochondrial and total glutathione (GSH) levels, and reduces liver injury in a mouse model of acetaminophen-induced liver injury partially via inhibition of the cytochrome P450 (CYP) isoforms CYP2E1, CYP1A2, and CYP3A11.

UsesSchisandrin C potently inhibits proprotein convertase subtillsin-kexin type 9 (PCSK9) mRNA expression. Also, it displays strong protective effects in SH-SY5Y cells against serum and glucose deprivation (SGD) injury.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
PubChem CID
119112
DTXSID
DTXSID101317497
Nikkaji
J431.366F
Symbol(GHS)
7 · GHS07,GHS09
Signal word
Warning
Hazard statements
302 · H302-H410
Precautionary statements
264 · P264-P270-P301+P312-P330-P501-P273-P391-P501
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids